GlassScriptPhysician profile
Darius C Desai
NPI 1669486882
$6,545.94
in general payments reported to CMS, 2019-2025
10 companies · $436 in 2025
The $436 reported for 2025 was more than what a typical Surgical Oncology provider received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $948 · 2020: $27.26 · 2021: $381 · 2022: $2,059 · 2023: $2,150 · 2024: $545 · 2025: $436.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,100 · Education: $1,068 · Travel and Lodging: $962.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,100.14 |
| Education | $1,068.49 |
| Travel and Lodging | $962.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,683.12 | 2019-2023 | Davinci Xi, Da Vinci Surgical System |
| Angiodynamics, INC. | $765.58 | 2019-2024 | Nanoknife |
| Ethicon US, LLC | $205.24 | 2021 | |
| Merck Sharp & Dohme LLC | $186.32 | 2024-2025 | |
| Dilon Technologies, INC. | $171.92 | 2024 | Hemoblast Bellows |
| Integra Lifesciences Corporation | $157.83 | 2025 | Duraseal Exact Spinal Sealant System, Cusa Clarity, Codman Certas |
| Boston Scientific Corporation | $124.74 | 2024 | Axios |
| Novocure INC. | $115.57 | 2025 | Optune Lua (Novottf-200t) |
| Astrazeneca Pharmaceuticals LP | $68.49 | 2025 | Imfinzi |
| Olympus America INC. | $67.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darius Desai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.